Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Tabula Rasa HealthCare Inc is a health information services business based in the US. Tabula Rasa HealthCare shares (TRHC) are listed on the NASDAQ and all prices are listed in US Dollars. Tabula Rasa HealthCare employs 1,614 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $11.18 |
|---|---|
| 52-week range | $10.05 - $69.31 |
| 50-day moving average | $13.50 |
| 200-day moving average | $31.64 |
| Wall St. target price | $21.41 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-3.83 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $11.18 from 2022-01-26
| 1 week (2022-01-21) | -20.09% |
|---|---|
| 1 month (2021-12-28) | -21.43% |
| 3 months (2021-10-28) | -58.42% |
| 6 months (2021-07-28) | -74.50% |
| 1 year (2021-01-28) | -79.68% |
|---|---|
| 2 years (2020-01-28) | -79.72% |
| 3 years (2019-01-28) | 58.43 |
| 5 years (2017-01-27) | 14.27 |
Valuing Tabula Rasa HealthCare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tabula Rasa HealthCare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tabula Rasa HealthCare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.2944. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tabula Rasa HealthCare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Tabula Rasa HealthCare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $691,000.
The EBITDA is a measure of a Tabula Rasa HealthCare's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $322.6 million |
|---|---|
| Gross profit TTM | $92.4 million |
| Return on assets TTM | -8.83% |
| Return on equity TTM | -76.15% |
| Profit margin | -27.37% |
| Book value | $2.87 |
| Market capitalisation | $339.2 million |
TTM: trailing 12 months
We're not expecting Tabula Rasa HealthCare to pay a dividend over the next 12 months.
Over the last 12 months, Tabula Rasa HealthCare's shares have ranged in value from as little as $10.05 up to $69.31. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tabula Rasa HealthCare's is 1.0502. This would suggest that Tabula Rasa HealthCare's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates through two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise software that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing programs or systems. The company also provides RxCompanion, a cloud-based MTM software platform designed to aid in the identification and resolution of medication and other health related problems; TruChart, a web-based electronic health record for Programs of All-Inclusive Care for the Elderly (PACE) organizations; PACElogic, which delivers real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state required reporting. In addition, the company offers DoseMeRx, a decision support software; PrescribeWellness, a patient engagement center platform; and clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2020, it served approximately 130 healthcare organizations; and 280 health plans and approximately 14,000 retail pharmacies.
Five major factors contribute to the continued bull run of Bitcoin, ARK says, including growing adoption and long-term focus of investors.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.